Cercar

27/12/2025 Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns
López-Yerena, A, Arroyo-Olivares, R, Santisteban, V, Muñoz-Garcia, N, Estruch, R, Mata, P, Badimon, L, Padro, T. Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns. Nutrients. 2025; 18(1)DOI:10.3390/nu18010092. PMID:41515209. IF:5.000(Q1/2D).
28/01/2026 A novel methodology to characterize beat-to-beat alternations in whole-cell calcium currents
Marimon, X, Cerrolaza, M, Tarifa, C, Hove-Madsen, L. A novel methodology to characterize beat-to-beat alternations in whole-cell calcium currents. PLoS One. 2026; 21(1)DOI:10.1371/journal.pone.0339890. PMID:41604389. IF:2.600(Q2/4D).
01/12/2025 Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
Svennberg, E, Merino, JL, Andrade, J, Anselmino, M, Arbelo, E, Boersma, E, Boriani, G, Breithardt, G, Chung, MN, Chyou, J, Cohen, A, Nielsen, JC, Dichtl, W, Diederichsen, SZ, Dobrev, D, Doehner, W, Dworatzek, E, Fabritz, L, Filgueiras-Rama, D, Gimpelewicz, C, Hack, G, Hatem, S, Healey, J, Heidbuchel, H, Hijazi, Z, Holst, AG, Hove-Madsen, L, Jalife, J, van Leerdam, R, Linz, D, Lip, GYH, Lubitz, S, de Melis, M, Meyer, R, Orczykowski, M, Parwani, AS, Porta-Sanchez, A, de Potter, T, Ravens, U, Rienstra, M, Rillig, A, Rivard, L, Scherr, D, Schnabel, RB, Schotten, U, Simovic, S, Sinner, M, Sohns, C, Sommer, P, Steinbeck, G, Steven, D, Sultan, A, Thomalla, G, Toennis, T, Tzeis, S, Voigt, N, Wadhwa, M, Wakili, R, Witt, H, Goette, A, Kirchhof, P. Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. EUROPACE. 2025; 27(12)DOI:10.1093/europace/euaf318. PMID:41392710. IF:7.400(Q1/2D).
16/01/2025 A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy
Llansó, L, Ravenscroft, G, Aceituno, C, Gutiérrez, A, Parmar, J, Gallano, P, Caballero-avila, M, Carbayo, A, Vesperinas, A, Collet, R, Blanco, R, Laing, N, Hove-Madsen, L, Gallardo, E, Olivé, M. A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2025; 51(1)DOI:10.1111/nan.70000. PMID:39817497. IF:3.400(Q1/3D).
01/12/2021 Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular Tachycardia.
Arslanova A, Shafaattalab S, Ye K, Asghari P, Lin L, Kim B, Roston TM, Hove-Madsen L, Van Petegem F, Sanatani S, Moore E, Lynn F, Søndergaard M, Luo Y, Chen SRW, Tibbits GF. Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular Tachycardia.. Current Protocols. 2021; 1(12)DOI:10.1002/cpz1.320. PMID:34958715. IF:(Q/D).
01/11/2025 Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization
Benitez-Amaro, A, Garcia, E, Lhoëst, MTL, Martínez, A, Borrás, C, Tondo, M, Céspedes, MV, Caruana, P, Pepe, A, Bochicchio, B, Cenarro, A, Civeira, F, Prades, R, Escola-Gil, JC, Llorente-Cortés, V. Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization. ATHEROSCLEROSIS. 2025; 410DOI:10.1016/j.atherosclerosis.2024.118630. PMID:39547850. IF:5.700(Q1/1D).
01/11/2023 Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas.
León X, Bagué S, Holgado A, Quer M, Terra X, Camacho M, Avilés-Jurado FX. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas.. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otoeng.2023.05.006. PMID:37730160. IF:(Q/D).
21/08/2023 Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain.
Muñoz AJ, Ortega L, Gutiérrez A, Gallardo E, Rubio-Rodríguez D, Rubio-Terrés C, Morón B, García-Alfonso P, Soria JM. Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain.. JOURNAL OF MEDICAL ECONOMICS. 2023; 26(1)DOI:10.1080/13696998.2023.2248839. PMID:37602646. IF:2.900(Q1/2D).